Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Six universities including Oxford have been awarded a total of £4.3m by the Medical Research Council (MRC) to grow and develop the UK’s research base in dementia science.

Zam Cader, leader of the Oxford Momentum Award

The Momentum awards, designed to support the UK Dementia Research Institute (DRI), will help open new research avenues which could transform the potential of dementia research in the UK. The awards represent the first steps in establishing the capabilities for the DRI, which is being funded through a combined investment of £250m from the MRC and founding charity partners, the Alzheimer’s Society and Alzheimer’s Research UK. The DRI is expected to be up and running by 2019.

The DRI will be the biggest single investment into dementia research the UK has ever seen and we are proud to start building the foundation for it now. These transformative awards will create exciting new opportunities across the dementia research landscape and provide impetus to allow the Institute to start making its mark as soon as it is launched.
- Dr Rob Buckle, director of science programmes at the MRC

Each award will enhance overall dementia research capacity in the UK and, crucially, will accelerate the recruitment of research leaders and ‘rising stars’ from both within and outside of the UK. The funding will also help current researchers develop promising connections between different research disciplines to bring new understanding to the field, as well as exploit emerging scientific opportunities and explore new approaches to fight the disease.

The Oxford Momentum Award is led by Zam Cader, who will be developing methods to better understand the epigenetics of microglia interactions in dementia. The other project leads for this multi-disciplinary programme are Sally Crowley, Francesca Nicholls, Florian Plattner and Caleb Webber.  The four projects are designed to develop key capabilities in the provision of human brain cell types, cell imaging analysis and targeting signalling pathways, and will include recruitment back to the UK of a researcher who currently holds a faculty appointment in the US.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

New Year's Honours for Professor Irene Tracey

Professor Irene Tracey FMedSci, MAE, Professor of Anaesthetic Neuroscience and Warden of Merton College, has been appointed CBE for services to medical research.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.

Nine new Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.